These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 9203372

  • 1. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
    Chang SC, MacRobert AJ, Porter JB, Bown SG.
    J Photochem Photobiol B; 1997 Apr; 38(2-3):114-22. PubMed ID: 9203372
    [Abstract] [Full Text] [Related]

  • 2. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
    Anayo L, Magnussen A, Perry A, Wood M, Curnow A.
    Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
    [Abstract] [Full Text] [Related]

  • 3. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
    Chang SC, Buonaccorsi G, MacRobert AJ, Bown SG.
    Lasers Surg Med; 1997 Jul; 20(3):254-64. PubMed ID: 9138254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
    Blake E, Allen J, Curnow A.
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors.
    Curnow A, Pye A.
    J Environ Pathol Toxicol Oncol; 2007 Dec; 26(2):89-103. PubMed ID: 17725535
    [Abstract] [Full Text] [Related]

  • 9. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid.
    Chang SC, MacRobert AJ, Bown SG.
    J Urol; 1996 May; 155(5):1744-8. PubMed ID: 8627876
    [Abstract] [Full Text] [Related]

  • 10. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
    Gronlund-Pakkanen S, Wahlfors J, Makinen K, Pakkanen TM, Talja M, Ala-Opas M, Alhava E, Moore RB.
    J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
    Xiao Z, Miller GG, McCallum TJ, Brown KM, Lown JW, Tulip J, Moore RB.
    Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
    Magnussen A, Reburn C, Perry A, Wood M, Curnow A.
    Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy.
    Grönlund-Pakkanen S, Mäkinen K, Talja M, Kuusisto A, Alhava E.
    J Photochem Photobiol B; 1997 Apr; 38(2-3):269-73. PubMed ID: 9203390
    [Abstract] [Full Text] [Related]

  • 18. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
    Lange N, Jichlinski P, Zellweger M, Forrer M, Marti A, Guillou L, Kucera P, Wagnières G, van den Bergh H.
    Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
    [Abstract] [Full Text] [Related]

  • 19. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
    Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG.
    Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
    [Abstract] [Full Text] [Related]

  • 20. The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
    Dogra Y, Ferguson DCJ, Dodd NJF, Smerdon GR, Curnow A, Winyard PG.
    Redox Biol; 2016 Oct; 9():90-99. PubMed ID: 27454766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.